ZyVersa Therapeutics, Inc. Warrants (ZVSAW)

ZVSAW was delisted on the 20th of December, 2022.

• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.